Clinical Trials

25 enrolled

GastrointestinalGynecologic

Mental Disorders, Ovarian Neoplasms

NCT01719926 2026-06-04

PIFA

Phase 1 Completed

13 enrolled

Esophageal Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT05887609 2026-06-04

An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib

53 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT07098182 2026-06-04

Contribution of Preserving the Superior Left Colic Artery to the Vascularization of the Descending Colon Prior to Colorectal Anastomosis During Left-Sided or Rectal Resections for Colorectal or Ovarian Cancer. (Revascularisation Colique)

GastrointestinalGynecologic

50 enrolled

Colonic Neoplasms, Ovarian Neoplasms, Rectal Neoplasms

NCT07625137 2026-06-04

Preventing Ovarian Cancer Through Opportunistic Salpingectomy at the Time of Laparoscopic Cholecystectomy

Phase NA Not yet recruiting

240 enrolled

Ovarian Neoplasms

NCT05523440 2026-06-03

Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation

Phase 2 Terminated

9 enrolled 10 charts

Ovarian Neoplasms, Endometrial Neoplasms

NCT06412120 2026-06-03

Study Evaluating Safety, Tolerability, and Metabolism of Niraparib

Phase 4 Recruiting

70 enrolled

Phase 1 Not yet recruiting

Ovarian Neoplasms

NCT07489287 2026-06-03

GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer

18 enrolled

Phase NA Active not recruiting

Ovarian Neoplasms

NCT04454450 2026-06-02

Using Advanced Imaging Studies to Develop a Profile of High-grade Serous Ovarian Cancer

10 enrolled

Phase NA Active not recruiting

Ovarian Neoplasms

NCT05056077 2026-06-02

TTBF

353 enrolled

BreastGastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

NCT05039801 2026-06-01

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

DermatologicGynecologicHead & NeckSarcoma

54 enrolled

Squamous Cell Carcinoma of Head and Neck, Chondrosarcoma, Melanoma, Ovarian Neoplasms, Endometrial Neoplasms

NCT05231122 2026-06-01

Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer

80 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05364879 2026-06-01

Prehabilitation for Ovarian Cancer Patients

108 enrolled

Frailty, Motor Activity, Ovarian Neoplasms

NCT07616310 2026-06-01

RSEnTrail

300 enrolled

Ovarian Neoplasms

NCT05743517 2026-05-29

Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)

192 enrolled

Uterine Cervical Neoplasms, Motor Activity, Ovarian Neoplasms, Uterine Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT06533332 2026-05-29

A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors

BreastGastrointestinalGynecologic

36 enrolled

Breast Neoplasms, Liver Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Endometrial Neoplasms

NCT06851663 2026-05-29

Trop2-targeted immunoPET Imaging of Solid Tumors

Phase 2/3 Recruiting

400 enrolled

GastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Nasopharyngeal Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT07614620 2026-05-29

HYPNO-AJA2

Phase NA Not yet recruiting

70 enrolled

BreastGenitourinaryGynecologicSarcoma

Testicular Germ Cell Tumor, Breast Neoplasms, Ovarian Neoplasms, Sarcoma

NCT04533763 2026-05-28

Living WELL: A Web-Based Program for Ovarian Cancer Survivors

Phase NA Completed

326 enrolled

Behavior, Ovarian Neoplasms

NCT06843629 2026-05-28

Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors

GastrointestinalGynecologicThoracic

100 enrolled

Adenocarcinoma of Lung, Ovarian Neoplasms, Pancreatic Neoplasms

NCT07259304 2026-05-28

Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors

CNSGastrointestinalGenitourinaryGynecologicLymphoidSarcoma

250 enrolled

Bone Neoplasms, Brain Neoplasms, Uterine Cervical Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin, Ovarian Neoplasms, Testicular Neoplasms, Colorectal Neoplasms, Central Nervous System Neoplasms, Carcinoma, Medullary

NCT03275298 2026-05-27

ESME OC

Suspended

13,331 enrolled

Ovarian Neoplasms

NCT05903807 2026-05-27

[68Ga]Ga-FAPI-46 PET/CT in Ovarian Cancer

Phase 2 Terminated

20 enrolled

Phase NA Not yet recruiting

Neoplasms, Ovarian Neoplasms

NCT07609082 2026-05-27

ADAPT-OC

36 enrolled

Ovarian Neoplasms

NCT06760507 2026-05-26

RSPH5973-23

3,209 enrolled

Phase 2 Not yet recruiting

Breast Neoplasms, Ovarian Neoplasms

NCT07495124 2026-05-26

IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence

26 enrolled

Phase 2 Active not recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03449108 2026-05-22

LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas

30 enrolled

BreastEndocrineGynecologicHead & NeckSarcoma

Bone Neoplasms, Ovarian Neoplasms, Sarcoma, Osteosarcoma, Giant Cell Tumor of Bone, Histiocytoma, Malignant Fibrous, Triple Negative Breast Neoplasms, Thyroid Carcinoma, Anaplastic

NCT04811703 2026-05-22

PIPACOVA

15 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT05225428 2026-05-22

VERDI

BreastDermatologicGastrointestinalGenitourinaryGynecologicSarcoma

1,020 enrolled

Breast Neoplasms, Kidney Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Colorectal Neoplasms

NCT05649072 2026-05-22

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

BreastGastrointestinalGynecologic

1,000 enrolled

Breast Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT06709872 2026-05-22

BIOC

400 enrolled

Disease, Ovarian Neoplasms

NCT03430700 2026-05-20

PROMPT

Phase 2 Completed

20 enrolled 10 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT04878094 2026-05-20

A Study of Intra-operative Imaging in Women With Ovarian Cancer

Phase 3 Recruiting

310 enrolled

Ovarian Neoplasms

NCT03180294 2026-05-19

Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer

Phase 2 Completed

230 enrolled 24 charts

Breast Neoplasms, Uterine Cervical Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

NCT06305299 2026-05-19

Autologous CAR-T Cells Targeting B7H3 in Ovarian Cancer iC9-CAR.B7-H3 T Cells

27 enrolled

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms, Recurrence

NCT01034033 2026-05-18

Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples

3,300 enrolled

Breast Neoplasms, Ovarian Neoplasms

NCT04701645 2026-05-18

Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer

20 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05429970 2026-05-18

A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)

35 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06083844 2026-05-18

Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline Therapy

20 enrolled

Ovarian Neoplasms

NCT07285044 2026-05-18

The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicLymphoidMyeloidPlasma cellThoracic

27 enrolled

Amyloidosis, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Basal Cell, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Glioblastoma, Carcinoma, Hepatocellular, Hodgkin Disease, Lung Neoplasms, Melanoma, Multiple Myeloma, Myelodysplastic Syndromes, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Endometrial Neoplasms, Lymphoma, Mantle-Cell

NCT07591831 2026-05-18

Liposomal Irinotecan Plus Enlonstobart for Platinum-Resistant Recurrent Ovarian Cancer

Phase 2 Not yet recruiting

30 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT07593833 2026-05-18

Prospective Sample Collection Study for a Blood-Based cfDNA Methylation Assay for Ovarian Cancer Detection

Not yet recruiting

1,000 enrolled

Disease, Ovarian Neoplasms

NCT07557225 2026-05-14

18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

200 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, von Hippel-Lindau Disease, Ovarian Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma, Small Cell Lung Carcinoma

NCT07586449 2026-05-14

RESO

Not yet recruiting

500 enrolled

Ovarian Neoplasms

NCT07586826 2026-05-14

N01-A-PICIT-GT

BreastClassical hematologyGynecologicThoracic

220 enrolled

Pathologic Complete Response, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Thrombocytopenia, Endometrial Neoplasms

NCT04214210 2026-05-13

DIALOGUE

Phase NA Completed

128 enrolled

Breast Neoplasms, Ovarian Neoplasms

NCT04295577 2026-05-13

MONITOR-UK

Completed

388 enrolled

Phase 1 Active not recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT04502602 2026-05-11

iNNOVATE

18 enrolled